Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 2 - What They Never Told You

Contineum Therapeutics' Multiple Sclerosis Trial Disappoints, But Analyst Sees Other Assets Driving Value

Contineum Therapeutics, Inc. (NASDAQ:CTNM) on Thursday shared topline data from its Phase 2 VISTA trial of PIPE-307, an M1 receptor antagonist for relapsing-remitting multiple sclerosis (RRMS).

Benzinga

Common virus jab could be key in fight against multiple sclerosis

The vaccine will be trialled in patients recently diagnosed with MS

The Independent UK

Gene on the X chromosome may help explain high multiple sclerosis rates in women

A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are higher in women than in men, scientists suggest.

LiveScience

From analysis to the latest developments in health,
read the most diverse news in one place.

Experts uncover reason why women are at higher risk of Alzheimer’s and MS

Multiple sclerosis and Alzheimer's disease each affect women more often than men, about two to three times as often, researchers say

The Independent UK

Zenas Biopharma Raises $120 Million To Secure Global Rights To Multiple Sclerosis Drug

Zenas BioPharma Inc. (NASDAQ:ZBIO) and InnoCare Pharma Ltd. on Wednesday announced a license agreement granting Zenas global development and commercialization rights to orelabrutinib for multiple sclerosis and across all therapeutic areas other than oncology.

Benzinga

Man who became popular in Blinking White Guy gif raises over $300,000 for multiple sclerosis research

Drew Scanlon, a resident of San Francisco, said the case was close to him a friend and his mother are afflicted with it

The Guardian - US

‘Exciting’ clinical results offer hope for new class of MS therapies

Cambridge trial suggests diabetes drug with antihistamine can partially repair damage in the nervous system

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

FDA Delays Key Sanofi Multiple Sclerosis Drug Decision

On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug application (NDA) of tolebrutinib for non-relapsing, secondary progressive multiple sclerosis (nrSPMS) and to slow disability accumulation independent of relapse activity in adult patients.

Benzinga

Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug

Quantum Biopharma Ltd. (NASDAQ:QNTM) announced on Tuesday that its subsidiary Huge Biopharma Australia has received the clinical study report for a Phase 1, randomized, double-blind, placebo-controlled multiple ascending dose trial evaluating the safety and pharmacokinetics of Lucid-MS in healthy adults.

Benzinga

Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate

Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% year over year, beating the analyst consensus of $4.06.

Benzinga

Christina Applegate: 'I miss who I was before I got sick'

Christina Applegate – who was diagnosed with multiple sclerosis in 2021 - admitted it was “like a knife to the heart” when her 14-year-old daughter Sadie shared how difficult she finds it coping with her mother’s illness.

BANG Premier

World-first study could provide MS breakthrough

A groundbreaking Australian study is using DNA analysis to pinpoint a person's genetic risk of developing multiple sclerosis.

AAP

Benefits cheat who said she couldn’t stand to cook caught after posting 10k run photos on Facebook

Sara Morris, 50, exaggerated how badly her multiple sclerosis affected her

The Independent UK

Scientists uncover possible missing link between 'mono' virus and multiple sclerosis

"Mono," caused by Epstein-Barr virus, raises the risk of multiple sclerosis, but it's unclear why. A study pinpoints a genetic variant that might help explain.

LiveScience

Get all your
news in one place.

100's of premium titles.
One news app.

BANG Premier

Selma Blair: I'm truly in remission from multiple sclerosis

Movie star Selma Blair has revealed that she's "in remission" from multiple sclerosis.

The Independent UK

Patients blamed for ‘faking’ symptoms of underdiagnosed brain disorder

Some lose the ability to walk or speak, then are reprimanded for exaggerating

The Conversation

Tremors, seizures and paralysis: this brain disorder is more common than multiple sclerosis – but often goes undiagnosed

Imagine suddenly losing the ability to move a limb, walk or speak. You would probably recognise this as a medical emergency and get to hospital.

The Guardian - UK

Biologist whose innovation saved the life of British teenager wins $3m Breakthrough prize

Prof David Liu is among the winners of 2025’s ‘Oscars of science’, with honours also going to researchers for landmark work on multiple sclerosis, particle physics and ‘skinny jabs’

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

$3 million Breakthrough Prize goes to scientists that completely changed our understanding of multiple sclerosis

Two prominent scientists who study multiple sclerosis — Dr. Alberto Ascherio and Dr. Stephen Hauser — are co-winners of a 2025 Breakthrough Prize in Life Sciences.

LiveScience

In a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of multiple sclerosis. However, much more research is warranted to confirm these findings.

Evening Standard

London leaver: 'I think we are better people in North Yorkshire'

When Jessica Lorimer’s doctor sat her down and told her that she was suffering from Myalgic encephalomyelitis (ME) her life changed forever. Not only would she have to cope with the multiple symptoms of the chronic disease, but she would also have to rethink her lifestyle completely.

The Independent UK

Sir Chris Hoy and wife Sarra are coping with health diagnoses ‘remarkably’, says Lorraine

Sir Chris has stage four prostate cancer and Lady Sarra, multiple sclerosis

The Guardian - UK

MS patients in England to benefit from major roll out of take-at-home pill

Cladribine tablet for those with active multiple sclerosis will reduce hospital visits and free up appointments

The Conversation

Out-of-balance bacteria is linked to multiple sclerosis − the ratio can predict severity of disease

Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It affects nearly one million people in the U.S. and over 2.8 million worldwide. While genetics play a role in the risk of developing multiple sclerosis, environmental factors such as diet, infectious…

Dynamite News

New drug may help restoring vision for people with nerve damage

Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in the restoration of vision in those suffering from multiple sclerosis (MS) and other neurodegenerative diseases. Read further on Dynamite News:

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Edinburgh

Science Photo Library

the University of California San Francisco

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.